IBC's Preclinical Development Forum is the only industry event evaluating new scientific advances and organizational strategies to optimize the transition toward first in human studies through discovery through development. Taking a comprehensive look at the interface between discover and development through scientific knowledge, innovative technologies and business strategies, this event will provide an assessment of where the industry has been in regard to ADMETox, PK/PD, pharmaceutical profiling, animal models and biomarkers and more importantly where it needs to go in order to impact attrition rate and productivity in a significant way. Open discussions will challenge and provoke the audience to think about what direction the industry must take in the future. For up-to-date information on this event and to register online, visit www.IBCLifeSciences.com/3056.